Skip to content

Analysis and Evaluation of the Application of Pre-prescription Screening System in Pediatric Hematology and Oncology

Analysis and Evaluation of the Application of Pre-prescription Screening System in Pediatric Hematology and Oncology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128777
Enrollment
Unknown
Registered
2026-07-25
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Hematology and Oncology

Interventions

Before the launch of the pre-review prescription system rules (The sample size refers to the number of doctor's orders):N/A
After the launch of the pre-review prescription system rules (The sample size refers to the number of doctor's orders):N/A
Questionnaire interview group:N/A

Sponsors

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Inpatient orders: All inpatient orders issued by the Department of Pediatric Hematology and Oncology during the research period; 2.Inpatient orders: Patients aged under 18 years; 3.Inpatient orders: Male or female; 4.Interviews: Active physicians, nurses, and pharmacists in the Department of Hematology and Oncology at our hospital who have experience using the pre-dispensing prescription review system; 5.Interviews: Male or female; 6.Interviews: Individuals who have signed the informed consent form for the interview;

Exclusion criteria

Exclusion criteria: 1.Inpatient orders: Patients with missing clinical information in hospital electronic medical record systems; 2.Inpatient orders: Researchers believe that the child's condition may interfere with participation in the study or may be unsuitable for participation; 3.Interviews: Researchers believe that the individual's condition may interfere with participation in the study or make participation inappropriate;

Design outcomes

Primary

MeasureTime frame
System interception rate;

Secondary

MeasureTime frame
Average audit time per prescription;Incidence of various types of inappropriate medical orders;Thematic analysis results of interviews;Physician acceptance rate of alerts;Forced submission rate;Average time for physicians to modify inappropriate orders;System Usability Scale (SUS) Score;Physician appeal rate;

Countries

China

Contacts

Public ContactWu Juan

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

wujuan@scmc.com.cn+86 18918397709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026